0001567619-21-007976.txt : 20210413
0001567619-21-007976.hdr.sgml : 20210413
20210413175530
ACCESSION NUMBER: 0001567619-21-007976
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210409
FILED AS OF DATE: 20210413
DATE AS OF CHANGE: 20210413
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: NODELMAN OLEG
CENTRAL INDEX KEY: 0001454385
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824034
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital Fund, L.P.
CENTRAL INDEX KEY: 0001567938
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824032
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital, LLC
CENTRAL INDEX KEY: 0001587114
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824033
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Biotech Opportunity GP, LLC
CENTRAL INDEX KEY: 0001816370
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824028
BUSINESS ADDRESS:
STREET 1: 1370 TRANCAS STREET, SUITE 176
CITY: NAPA
STATE: CA
ZIP: 94558
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 1370 TRANCAS STREET, SUITE 176
CITY: NAPA
STATE: CA
ZIP: 94558
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Venture Opportunity Fund, LP
CENTRAL INDEX KEY: 0001778011
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824030
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Capital Fund Qualified, L.P.
CENTRAL INDEX KEY: 0001598292
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824031
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: 415-448-6534
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET #3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: EcoR1 Panacea Holdings, LLC
CENTRAL INDEX KEY: 0001816134
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39351
FILM NUMBER: 21824029
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Nuvation Bio Inc.
CENTRAL INDEX KEY: 0001811063
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 850862255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
BUSINESS PHONE: (415) 754-3517
MAIL ADDRESS:
STREET 1: 357 TEHAMA STREET, FLOOR 3
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94103
FORMER COMPANY:
FORMER CONFORMED NAME: Panacea Acquisition Corp
DATE OF NAME CHANGE: 20200430
4
1
doc1.xml
FORM 4
X0306
4
2021-04-09
0
0001811063
Nuvation Bio Inc.
NUVB
0001454385
NODELMAN OLEG
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
1
0
0
0
0001587114
EcoR1 Capital, LLC
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
0001567938
EcoR1 Capital Fund, L.P.
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
0001598292
EcoR1 Capital Fund Qualified, L.P.
409 ILLINOIS STREET
SAN FRANCISCO
CA
94158
0
0
1
0
0001778011
EcoR1 Venture Opportunity Fund, LP
357 TEHAMA STREET #3
SAN FRANCISCO
CA
94103
0
0
1
0
0001816134
EcoR1 Panacea Holdings, LLC
357 TEHAMA STREET, FLOOR 3
SAN FRANCISCO
CA
94103
0
0
1
0
0001816370
Biotech Opportunity GP, LLC
1370 TRANCAS STREET, SUITE 176
NAPA
CA
94558
0
0
1
0
Class A Common Stock
2021-04-09
4
P
0
262230
10.0306
A
6846476
I
See Notes 1 and 2
Class A Common Stock
2021-04-09
4
P
0
37770
10.0306
A
1334914
I
See Notes 1 and 3
Class A Common Stock
2021-04-12
4
P
0
116255
9.4878
A
6962731
I
See Notes 1 and 2
Class A Common Stock
2021-04-12
4
P
0
16745
9.4878
A
1351659
I
See Notes 1 and 3
Class A Common Stock
2021-04-13
4
P
0
27534
10.271
A
6990265
I
See Notes 1 and 2
Class A Common Stock
2021-04-13
4
P
0
3966
10.271
A
1355625
I
See Notes 1 and 3
Class A Common Stock
3165000
I
See Notes 1 and 4
Class A Common Stock
2200627
I
See Notes 1 and 5
EcoR1 Capital, LLC ("EcoR1") is the investment adviser to EcoR1 Capital Fund, L.P. ("Capital Fund"), EcoR1 Capital Fund Qualified, L.P. ("Qualified Fund") and EcoR1 Venture Opportunity Fund, L.P. ("Venture Fund"). EcoR1 is the general partner of Capital Fund and Qualified Fund, and Biotech Opportunity GP, LLC ("Biotech") is the general partner of Venture Fund. Mr. Nodelman is the manager and controlling owner of EcoR1 and Biotech. The funds hold these securities directly for the benefit of their investors. EcoR1 indirectly beneficially owns them as the investment adviser to the funds. Mr. Nodelman indirectly beneficially owns them as the control person of EcoR1. The Reporting Persons disclaim beneficial ownership of such securities except to the extent of their pecuniary interest therein.
Qualified Fund is the record holder of these securities.
Capital Fund is the record holder of these securities.
EcoR1 Panacea Holdings, LLC, which is the owner of record of these securities, is managed by its managing members, Capital Fund, Qualified Fund and Venture Fund. Each of the Reporting Persons may be deemed a beneficial owner of shares held by EcoR1 Panacea Holdings, LLC, but each Reporting Person disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein.
These securities are held of record by Venture Fund. Biotech indirectly beneficially owns these securities as the general partner of Venture Fund, and Mr. Nodelman indirectly beneficially owns these securities as the control person of Biotech and EcoR1.
The Reporting Persons are filing this Form 4 jointly, but not as a group, and each expressly disclaims membership in a group within the meaning of Rule 13d-5(b) under the Securities Exchange Act of 1934, as amended. Mr. Nodelman serves on the board of directors of the issuer. For the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each of the Reporting Persons (other than Mr. Nodelman) may be deemed a director by deputization with respect to the issuer on the basis of Mr. Nodelman's service on the issuer's board of directors.
Oleg Nodelman, individually and as Manager of EcoR1 Capital, LLC and Biotech Opportunity GP, LLC
2021-04-13